{"id":2594,"date":"2021-08-03T16:18:16","date_gmt":"2021-08-03T06:18:16","guid":{"rendered":"\/eu-uk\/?p=2594"},"modified":"2021-09-16T15:08:19","modified_gmt":"2021-09-16T05:08:19","slug":"video-proactive-investors-orthocell-highlights-potential-for-celgro-in-treatment-of-lymphedema","status":"publish","type":"post","link":"\/eu-uk\/blog\/2021\/08\/03\/video-proactive-investors-orthocell-highlights-potential-for-celgro-in-treatment-of-lymphedema\/","title":{"rendered":"Video | Proactive Investors &#8211; Orthocell highlights potential for CelGro in treatment of lymphedema"},"content":{"rendered":"<p>Orthocell CEO and Managing Director Paul Anderson speaks to Proactive after announcing a breakthrough tissue engineering study, combining CelGro\u2122 with lymphatic and blood vessel cells to create functional lymphatic tissue, has been published in the Proceedings of the National Academy of Sciences of the United States of America (PNAS).<\/p>\n<p><iframe loading=\"lazy\" title=\"YouTube video player\" src=\"https:\/\/www.youtube.com\/embed\/aNfw4pIu18U\" width=\"1280\" height=\"720\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Orthocell CEO and Managing Director Paul Anderson speaks to Proactive after announcing a breakthrough tissue engineering study, combining CelGro\u2122 with lymphatic and blood vessel cells to create functional lymphatic tissue, has been published in the Proceedings of the National Academy of Sciences of the United States of America (PNAS).<\/p>\n","protected":false},"author":2,"featured_media":2622,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[3,1],"tags":[],"class_list":["post-2594","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-media","category-video"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 4.9.9 - aioseo.com -->\n\t<meta name=\"description\" content=\"Orthocell CEO and Managing Director Paul Anderson speaks to Proactive after announcing a breakthrough tissue engineering study, combining CelGro\u2122 with lymphatic and blood vessel cells to create functional lymphatic tissue, has been published in the Proceedings of the National Academy of Sciences of the United States of America (PNAS).\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"Orthocell\"\/>\n\t<link rel=\"canonical\" href=\"\/eu-uk\/blog\/2021\/08\/03\/video-proactive-investors-orthocell-highlights-potential-for-celgro-in-treatment-of-lymphedema\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 4.9.9\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_GB\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Orthocell EU\/UK -\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Video | Proactive Investors \u2013 Orthocell highlights potential for CelGro in treatment of lymphedema - Orthocell EU\/UK\" \/>\n\t\t<meta property=\"og:description\" content=\"Orthocell CEO and Managing Director Paul Anderson speaks to Proactive after announcing a breakthrough tissue engineering study, combining CelGro\u2122 with lymphatic and blood vessel cells to create functional lymphatic tissue, has been published in the Proceedings of the National Academy of Sciences of the United States of America (PNAS).\" \/>\n\t\t<meta property=\"og:url\" content=\"\/eu-uk\/blog\/2021\/08\/03\/video-proactive-investors-orthocell-highlights-potential-for-celgro-in-treatment-of-lymphedema\/\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2021-08-03T06:18:16+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2021-09-16T05:08:19+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Video | Proactive Investors \u2013 Orthocell highlights potential for CelGro in treatment of lymphedema - Orthocell EU\/UK\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Orthocell CEO and Managing Director Paul Anderson speaks to Proactive after announcing a breakthrough tissue engineering study, combining CelGro\u2122 with lymphatic and blood vessel cells to create functional lymphatic tissue, has been published in the Proceedings of the National Academy of Sciences of the United States of America (PNAS).\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2021\\\/08\\\/03\\\/video-proactive-investors-orthocell-highlights-potential-for-celgro-in-treatment-of-lymphedema\\\/#blogposting\",\"name\":\"Video | Proactive Investors \\u2013 Orthocell highlights potential for CelGro in treatment of lymphedema - Orthocell EU\\\/UK\",\"headline\":\"Video | Proactive Investors &#8211; Orthocell highlights potential for CelGro in treatment of lymphedema\",\"author\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/author\\\/hcartres\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/wp-content\\\/uploads\\\/sites\\\/6\\\/2021\\\/08\\\/Proactive_lymphedema.png\",\"width\":977,\"height\":550},\"datePublished\":\"2021-08-03T16:18:16+10:00\",\"dateModified\":\"2021-09-16T15:08:19+10:00\",\"inLanguage\":\"en-GB\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2021\\\/08\\\/03\\\/video-proactive-investors-orthocell-highlights-potential-for-celgro-in-treatment-of-lymphedema\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2021\\\/08\\\/03\\\/video-proactive-investors-orthocell-highlights-potential-for-celgro-in-treatment-of-lymphedema\\\/#webpage\"},\"articleSection\":\"Media, Video\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2021\\\/08\\\/03\\\/video-proactive-investors-orthocell-highlights-potential-for-celgro-in-treatment-of-lymphedema\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/category\\\/video\\\/#listItem\",\"name\":\"Video\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/category\\\/video\\\/#listItem\",\"position\":2,\"name\":\"Video\",\"item\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/category\\\/video\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2021\\\/08\\\/03\\\/video-proactive-investors-orthocell-highlights-potential-for-celgro-in-treatment-of-lymphedema\\\/#listItem\",\"name\":\"Video | Proactive Investors &#8211; Orthocell highlights potential for CelGro in treatment of lymphedema\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2021\\\/08\\\/03\\\/video-proactive-investors-orthocell-highlights-potential-for-celgro-in-treatment-of-lymphedema\\\/#listItem\",\"position\":3,\"name\":\"Video | Proactive Investors &#8211; Orthocell highlights potential for CelGro in treatment of lymphedema\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/category\\\/video\\\/#listItem\",\"name\":\"Video\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/#organization\",\"name\":\"Orthocell EU\\\/UK\",\"url\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/author\\\/hcartres\\\/#author\",\"url\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/author\\\/hcartres\\\/\",\"name\":\"Orthocell\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2021\\\/08\\\/03\\\/video-proactive-investors-orthocell-highlights-potential-for-celgro-in-treatment-of-lymphedema\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0aab809366bb46167bf34d1c56223f53c568b96a5870f19d01139e3e4a20c2f1?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"Orthocell\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2021\\\/08\\\/03\\\/video-proactive-investors-orthocell-highlights-potential-for-celgro-in-treatment-of-lymphedema\\\/#webpage\",\"url\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2021\\\/08\\\/03\\\/video-proactive-investors-orthocell-highlights-potential-for-celgro-in-treatment-of-lymphedema\\\/\",\"name\":\"Video | Proactive Investors \\u2013 Orthocell highlights potential for CelGro in treatment of lymphedema - Orthocell EU\\\/UK\",\"description\":\"Orthocell CEO and Managing Director Paul Anderson speaks to Proactive after announcing a breakthrough tissue engineering study, combining CelGro\\u2122 with lymphatic and blood vessel cells to create functional lymphatic tissue, has been published in the Proceedings of the National Academy of Sciences of the United States of America (PNAS).\",\"inLanguage\":\"en-GB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2021\\\/08\\\/03\\\/video-proactive-investors-orthocell-highlights-potential-for-celgro-in-treatment-of-lymphedema\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/author\\\/hcartres\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/author\\\/hcartres\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/wp-content\\\/uploads\\\/sites\\\/6\\\/2021\\\/08\\\/Proactive_lymphedema.png\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2021\\\/08\\\/03\\\/video-proactive-investors-orthocell-highlights-potential-for-celgro-in-treatment-of-lymphedema\\\/#mainImage\",\"width\":977,\"height\":550},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2021\\\/08\\\/03\\\/video-proactive-investors-orthocell-highlights-potential-for-celgro-in-treatment-of-lymphedema\\\/#mainImage\"},\"datePublished\":\"2021-08-03T16:18:16+10:00\",\"dateModified\":\"2021-09-16T15:08:19+10:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/#website\",\"url\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/\",\"name\":\"Orthocell EU\\\/UK\",\"inLanguage\":\"en-GB\",\"publisher\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Video | Proactive Investors \u2013 Orthocell highlights potential for CelGro in treatment of lymphedema - Orthocell EU\/UK","description":"Orthocell CEO and Managing Director Paul Anderson speaks to Proactive after announcing a breakthrough tissue engineering study, combining CelGro\u2122 with lymphatic and blood vessel cells to create functional lymphatic tissue, has been published in the Proceedings of the National Academy of Sciences of the United States of America (PNAS).","canonical_url":"\/eu-uk\/blog\/2021\/08\/03\/video-proactive-investors-orthocell-highlights-potential-for-celgro-in-treatment-of-lymphedema\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"\/eu-uk\/blog\/2021\/08\/03\/video-proactive-investors-orthocell-highlights-potential-for-celgro-in-treatment-of-lymphedema\/#blogposting","name":"Video | Proactive Investors \u2013 Orthocell highlights potential for CelGro in treatment of lymphedema - Orthocell EU\/UK","headline":"Video | Proactive Investors &#8211; Orthocell highlights potential for CelGro in treatment of lymphedema","author":{"@id":"\/eu-uk\/blog\/author\/hcartres\/#author"},"publisher":{"@id":"\/eu-uk\/#organization"},"image":{"@type":"ImageObject","url":"\/eu-uk\/wp-content\/uploads\/sites\/6\/2021\/08\/Proactive_lymphedema.png","width":977,"height":550},"datePublished":"2021-08-03T16:18:16+10:00","dateModified":"2021-09-16T15:08:19+10:00","inLanguage":"en-GB","mainEntityOfPage":{"@id":"\/eu-uk\/blog\/2021\/08\/03\/video-proactive-investors-orthocell-highlights-potential-for-celgro-in-treatment-of-lymphedema\/#webpage"},"isPartOf":{"@id":"\/eu-uk\/blog\/2021\/08\/03\/video-proactive-investors-orthocell-highlights-potential-for-celgro-in-treatment-of-lymphedema\/#webpage"},"articleSection":"Media, Video"},{"@type":"BreadcrumbList","@id":"\/eu-uk\/blog\/2021\/08\/03\/video-proactive-investors-orthocell-highlights-potential-for-celgro-in-treatment-of-lymphedema\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/orthocell.com\/eu-uk#listItem","position":1,"name":"Home","item":"https:\/\/orthocell.com\/eu-uk","nextItem":{"@type":"ListItem","@id":"\/eu-uk\/blog\/category\/video\/#listItem","name":"Video"}},{"@type":"ListItem","@id":"\/eu-uk\/blog\/category\/video\/#listItem","position":2,"name":"Video","item":"\/eu-uk\/blog\/category\/video\/","nextItem":{"@type":"ListItem","@id":"\/eu-uk\/blog\/2021\/08\/03\/video-proactive-investors-orthocell-highlights-potential-for-celgro-in-treatment-of-lymphedema\/#listItem","name":"Video | Proactive Investors &#8211; Orthocell highlights potential for CelGro in treatment of lymphedema"},"previousItem":{"@type":"ListItem","@id":"https:\/\/orthocell.com\/eu-uk#listItem","name":"Home"}},{"@type":"ListItem","@id":"\/eu-uk\/blog\/2021\/08\/03\/video-proactive-investors-orthocell-highlights-potential-for-celgro-in-treatment-of-lymphedema\/#listItem","position":3,"name":"Video | Proactive Investors &#8211; Orthocell highlights potential for CelGro in treatment of lymphedema","previousItem":{"@type":"ListItem","@id":"\/eu-uk\/blog\/category\/video\/#listItem","name":"Video"}}]},{"@type":"Organization","@id":"\/eu-uk\/#organization","name":"Orthocell EU\/UK","url":"\/eu-uk\/"},{"@type":"Person","@id":"\/eu-uk\/blog\/author\/hcartres\/#author","url":"\/eu-uk\/blog\/author\/hcartres\/","name":"Orthocell","image":{"@type":"ImageObject","@id":"\/eu-uk\/blog\/2021\/08\/03\/video-proactive-investors-orthocell-highlights-potential-for-celgro-in-treatment-of-lymphedema\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/0aab809366bb46167bf34d1c56223f53c568b96a5870f19d01139e3e4a20c2f1?s=96&d=mm&r=g","width":96,"height":96,"caption":"Orthocell"}},{"@type":"WebPage","@id":"\/eu-uk\/blog\/2021\/08\/03\/video-proactive-investors-orthocell-highlights-potential-for-celgro-in-treatment-of-lymphedema\/#webpage","url":"\/eu-uk\/blog\/2021\/08\/03\/video-proactive-investors-orthocell-highlights-potential-for-celgro-in-treatment-of-lymphedema\/","name":"Video | Proactive Investors \u2013 Orthocell highlights potential for CelGro in treatment of lymphedema - Orthocell EU\/UK","description":"Orthocell CEO and Managing Director Paul Anderson speaks to Proactive after announcing a breakthrough tissue engineering study, combining CelGro\u2122 with lymphatic and blood vessel cells to create functional lymphatic tissue, has been published in the Proceedings of the National Academy of Sciences of the United States of America (PNAS).","inLanguage":"en-GB","isPartOf":{"@id":"\/eu-uk\/#website"},"breadcrumb":{"@id":"\/eu-uk\/blog\/2021\/08\/03\/video-proactive-investors-orthocell-highlights-potential-for-celgro-in-treatment-of-lymphedema\/#breadcrumblist"},"author":{"@id":"\/eu-uk\/blog\/author\/hcartres\/#author"},"creator":{"@id":"\/eu-uk\/blog\/author\/hcartres\/#author"},"image":{"@type":"ImageObject","url":"\/eu-uk\/wp-content\/uploads\/sites\/6\/2021\/08\/Proactive_lymphedema.png","@id":"\/eu-uk\/blog\/2021\/08\/03\/video-proactive-investors-orthocell-highlights-potential-for-celgro-in-treatment-of-lymphedema\/#mainImage","width":977,"height":550},"primaryImageOfPage":{"@id":"\/eu-uk\/blog\/2021\/08\/03\/video-proactive-investors-orthocell-highlights-potential-for-celgro-in-treatment-of-lymphedema\/#mainImage"},"datePublished":"2021-08-03T16:18:16+10:00","dateModified":"2021-09-16T15:08:19+10:00"},{"@type":"WebSite","@id":"\/eu-uk\/#website","url":"\/eu-uk\/","name":"Orthocell EU\/UK","inLanguage":"en-GB","publisher":{"@id":"\/eu-uk\/#organization"}}]},"og:locale":"en_GB","og:site_name":"Orthocell EU\/UK -","og:type":"article","og:title":"Video | Proactive Investors \u2013 Orthocell highlights potential for CelGro in treatment of lymphedema - Orthocell EU\/UK","og:description":"Orthocell CEO and Managing Director Paul Anderson speaks to Proactive after announcing a breakthrough tissue engineering study, combining CelGro\u2122 with lymphatic and blood vessel cells to create functional lymphatic tissue, has been published in the Proceedings of the National Academy of Sciences of the United States of America (PNAS).","og:url":"\/eu-uk\/blog\/2021\/08\/03\/video-proactive-investors-orthocell-highlights-potential-for-celgro-in-treatment-of-lymphedema\/","article:published_time":"2021-08-03T06:18:16+00:00","article:modified_time":"2021-09-16T05:08:19+00:00","twitter:card":"summary_large_image","twitter:title":"Video | Proactive Investors \u2013 Orthocell highlights potential for CelGro in treatment of lymphedema - Orthocell EU\/UK","twitter:description":"Orthocell CEO and Managing Director Paul Anderson speaks to Proactive after announcing a breakthrough tissue engineering study, combining CelGro\u2122 with lymphatic and blood vessel cells to create functional lymphatic tissue, has been published in the Proceedings of the National Academy of Sciences of the United States of America (PNAS)."},"aioseo_meta_data":[],"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/orthocell.com\/eu-uk\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"\/eu-uk\/blog\/category\/video\/\" title=\"Video\">Video<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tVideo | Proactive Investors \u2013 Orthocell highlights potential for CelGro in treatment of lymphedema\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/orthocell.com\/eu-uk"},{"label":"Video","link":"\/eu-uk\/blog\/category\/video\/"},{"label":"Video | Proactive Investors &#8211; Orthocell highlights potential for CelGro in treatment of lymphedema","link":"\/eu-uk\/blog\/2021\/08\/03\/video-proactive-investors-orthocell-highlights-potential-for-celgro-in-treatment-of-lymphedema\/"}],"_links":{"self":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/posts\/2594","targetHints":{"allow":["GET"]}}],"collection":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/comments?post=2594"}],"version-history":[{"count":1,"href":"\/eu-uk\/wp-json\/wp\/v2\/posts\/2594\/revisions"}],"predecessor-version":[{"id":2595,"href":"\/eu-uk\/wp-json\/wp\/v2\/posts\/2594\/revisions\/2595"}],"wp:featuredmedia":[{"embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/media\/2622"}],"wp:attachment":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/media?parent=2594"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/categories?post=2594"},{"taxonomy":"post_tag","embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/tags?post=2594"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}